07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Center <strong>for</strong> Behavioral <strong>Neuroscience</strong> NSF agreement #IBN-9876754<br />

FACES NSF Award #0450303 Subaward # I-66-606-63<br />

<strong>Title</strong>: Systemic rapamycin disrupts the consolidation of context but not cued fear memory<br />

Authors: *E. M. GLOVER 1 , M. DAVIS 2 ;<br />

1 Dept Psychol, Ctr. Behav Neurosci, Emory Univ., Atlanta, GA; 2 Dept Psychiat & Behavioral<br />

Sci., Emory Univ. Sch. Med., Atlanta, GA<br />

<strong>Abstract</strong>: The mammalian target of rapamycin (mTOR) kinase regulates protein synthesis.<br />

Rapamycin, an mTOR kinase inhibitor, was recently shown to disrupt the consolidation of toneshock<br />

and context-shock fear memories (assessed with freezing) when infused into the amygdala<br />

(Parsons et al., 2006) immediately after training, and also context-shock memories (also assessed<br />

with freezing) when injected systemically either be<strong>for</strong>e or after training (Blundell et al., 2008).<br />

Because rapamycin is centrally active following systemic administration and is FDA-approved<br />

<strong>for</strong> use in humans, it has recently attracted interest as a possible prophylactic treatment <strong>for</strong><br />

PTSD-associated fear memories. To evaluate the generality of rapamycin effects on fear memory<br />

consolidation, we assess here the effects of systemic rapamycin injections on the consolidation of<br />

odor-shock and context-shock fear memories using fear-potentiated startle (FPS) as an<br />

alternative fear measure. On each of 2 consecutive days, rats received a pre-conditioning test<br />

during which their startle response to 30 95-dB noise bursts (noise alone test trial) was measured.<br />

Twenty-four hours later, they were returned to the chamber where they received a single 4-sec<br />

odor stimulus (5% amyl acetate) and co-terminating footshock (0.4 mA, 0.5-sec) and,<br />

immediately afterwards, an i.p. injection of either rapamycin (40 mg/kg) or vehicle. 7 days later,<br />

they were returned to test cage where they received 70 startle-eliciting noise bursts, of which 10<br />

of the final 40 were preceded by the odor conditioned stimulus. For some rats, the training and<br />

test contexts were identical. For others, the test context was altered (i.e., sandpaper inserts over<br />

the shock bars, Velcro on the sides, and 2 chains suspended from the top). Rapamycin<br />

significantly reduced FPS to the context CS (calculated as the percent change in startle from the<br />

pre-training test to the initial 30 noise alone trials of the post-conditioning test) but, in contrast to<br />

Parsons et al. (2006), did not reduce FPS to the discrete cue CS (calculated as the percent change<br />

in startle amplitude from noise alone to odor-noise test trials). This may reflect the different<br />

modalities used in these two studies (i.e., tone vs. odor) or, alternatively, a greater sensitivity of<br />

discrete cue fear conditioning to intra-amygdala vs. systemic rapamycin administration - a result<br />

similar to that seen with many other systemically administered compounds which selectively<br />

disrupt hippocampal-dependent (i.e., context fear or inhibitory avoidance) but not hippocampalindependent<br />

fear memories. If the latter, then this selectivity may limit the effectiveness of<br />

mTOR inhibitors as a PTSD treatment.<br />

Disclosures: E.M. Glover, None; M. Davis, None.<br />

Poster

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!